Unlocking the potential of mucoadhesive drug delivery
Drug Discovery World
OCTOBER 19, 2022
At each stage, there is a continued process of attrition that ultimately limits the number of new APIs making it to the clinical phases, and approximately 90% of new drug candidates advancing to clinical trials fail to achieve final drug approval 2,3. . Consider drug delivery systems early on .
52 
Let's personalize your content